Roche Stories

Democratising healthcare

Cross-sector collaborations are making healthcare more democratic, accessible and effective.

Every Cancer Is Unique. Let’s Treat It That Way.

Every cancer is unique. Discover how genomic testing can reveal mutations in a cancer tumour that can guide personalised treatment decisions.

HIV - From life ending to life changing

40 years of progress in HIV/AIDS diagnostics.

Hunting for solutions

Find out how Roche is harnessing the latest technology to treat Huntington’s disease.

World Diabetes Day 2019

November 14 is World Diabetes Day. The day was initiated in response to the growing concerns about the health risks diabetes poses.

Our Roche Innovation Centers

Our organisation has more than 2,200 scientists at seven Roche Innovation Centers spanning each major continent

Giving and getting advice: The power of mentoring

Carla Boragno shares the value of mentoring and the opportunity it provides to drive change and innovation.

Lung Cancer Awareness Month: An evolution

By continuing to challenge the stigma associated with lung cancer, we hope to drive improved outcomes for patients this November and beyond.

The future is patient-centric and data-driven

Tim M. Jaeger talks about the future of healthcare, the power of knowing and why human interaction will remain indispensable in the age of AI.

Investors reporting center

Shaping the future of cancer care

Combining science, partnerships and analytics in the fight against cancer.

Global Access Program

According to the World Health Organization (WHO), there were 35 million people living with HIV around the world in 2012. That same year 2.5 million people became newly infected with HIV worldwide.

Levi Garraway: A passion for purpose

Levi Garraway has officially started his new leadership role as Roche’s chief medical officer. Read Garraway’s story.

Roche at ESMO 2019

Learn about our activities at ESMO this year, and how we are working towards improved outcomes for patients.

Minimise the environmental footprint

Since the early 2000s Roche has been working towards a low-carbon future.

Taking a stand against cancer

All you need to know about the people and the important work at Roche Pharma Research and Early Development (pRED) Oncology as we discover the future in cancer care.

Would you share your health data?

Most patients are willing to share their data to contribute to medical progress, but they want transparency.

When patients are fully in control of their healthcare data

Partnering directly with patients opens up exciting ways to transparently share data and gain access to some of the richest datasets available to researchers.

What patients in clinical trials should know about their data

Patients can be at risk of sharing too much, especially in Rare diseases. How can patient advocates support innovation but also defend patient privacy?

Learn more about the work of pRED oncology at Roche

Christian Rommel, Global Head of pRED Oncology, gives his perspectives on cancer research in Roche and beyond.

Personalised healthcare and the complexity of data sharing

Mark Lee & Tim Jaeger discuss the shifting the paradigm of transparency and patient privacy when it comes to data

Understanding myopic choroidal neovascularisation

Myopic choroidal neovascularisation (mCNV) is a complication of severe short-sightedness that can lead to blindness.

Understanding neuromyelitis optica spectrum disorder

Neuromyelitis optica spectrum disorder (NMOSD) is a rare, lifelong and debilitating autoimmune disease of the central nervous system (CNS) that primarily damages the optic nerve and the spinal cord.

Understanding geographic atrophy

Geographic atrophy, an advanced form of age-related macular degeneration (AMD), can have a devastating impact on vision.

Understanding retinal vein occlusion

Learn more about retinal vein occlusion (RVO) a serious eye disease that affects the retina, a part of the eye that sends information to the brain enabling sight.

Understanding diabetic eye disease

If you have diabetes, it's important to know what is going on in the back of your eyes. Diabetic eye disease may lead to vision loss.

Seeing the unseen with artificial intelligence

AI could change the way ophthalmologists diagnose eye conditions like diabetic macular edema.

Understanding neovascular age-related macular degeneration

Learn about neovascular age-related macular degeneration, a leading cause of vision loss for people over 60.

The value of diagnostics in heart failure management

Heart failure affects millions of people and despite improvement in care, management remains challenging. Biomarkers can help patients at every stage of care.

Calculating the unimaginable

Quantum computers promise to offer computing power far beyond anything we can imagine.

Just the other day, I realised I could open the fridge again

Conversations with people with SMA and their families

Healthy liver, healthy lives

The liver is your body’s chemical processing plant, a powerhouse crucial to remove toxins; but liver cancer is on the rise. Learn what we can do to change this.

Roche results for half-year 2019

When everyday counts, data makes a meaningful difference for patients

Roche in Haemophilia

Find out more about haemophilia A and how Roche is developing novel approaches to hopefully advance the management of this serious disorder.

Personalised Healthcare

Working in both Pharmaceuticals and Diagnostics, we are uniquely positioned to fit the treatment to the patients.

A conversation with Roland Beckmann, inventor of the DutaMab technology

Interview with Dutalys co-founder and inventor of the DutaMab technology platform, Roland Beckmann, on his invention and journey founding a biotech.

Improving the supply chain

Gaps in the supply chain resulted in cost mark-ups putting modern cancer therapies out of reach for patients in sub-Saharan Africa.

Scaling up cancer care

Personalised healthcare is becoming a reality across the continuum of cancer care, from the nanoscale to the national.

Partnering to drive innovation in cancer immunotherapy

We’re partnering with many different stakeholders to find the most effective way for the immune system to identify and kill cancer cells.

Roche at the ASCO Annual Meeting 2019

Learn how we are working to help define the personalised cancer patient journeys of tomorrow.

Our philanthropic journey

Over 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.

How machine learning is transforming healthcare

Advanced analytics provide novel insights that could help to tackle some of the most complex problems in healthcare.

Tumour-agnostic treatments: A radical new approach to tackling cancer

Learn how tumour-agnostic approaches have the potential to change the way we diagnose, and treat, cancer in the future.

An introduction to personalised healthcare for the eye

Insights on how personalised healthcare can bring meaningful benefits to patients with retinal diseases

Inflammatory bowel diseases

We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.

Master the art of detection for skin cancer

Take a tour of our virtual gallery and learn to master the art of detection for skin cancer. It could help you save lives.

Life with NMOSD: Staying who you are with a rare disease

“Do not take life for granted. Take every moment in.”

Getting closer to cancer research's holy grail

Combining clinical and genomic data to advance personalised healthcare.

Fighting counterfeits to protect patients

For patients whose lives depend on prescription medicines, the consequences of counterfeiting are dramatic.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Small cell, big difference

Understanding what makes small cell lung cancer unique and what is being done to improve the lives of people with small cell lung cancer.

What is Personalised Healthcare?

Personalised healthcare is about providing the right treatment for the right patient. Fitting treatments to patients has always been the objective of medicine, of course. But only recent advances in science and technology have made this possible.

Exposing the impact of progression in multiple sclerosis

Pieter shares his experiences of progression in MS, and how virtual reality can help facilitate discussions about progression within the MS community.

Balance for better

Why is it important for businesses and society to create better gender balance? Hear the aspirations from our own people.

Roche in rare diseases

Find out what makes a rare disease rare and who is affected.

Annual Report 2018 Highlights

How digital innovation increases patient benefit in the future.

Elevating the patient voice in Huntington’s disease

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

Staying active despite progression: Anat’s Story

Explore Anat’s powerful message of staying active despite her progression in multiple sclerosis.

Partnering to fulfill the promise of personalised healthcare

The promise of personalised healthcare is a simple one: finding the right treatment for every patient. Through strategic partnerships, Roche is committed to fulfilling that promise.

Medical software and the value of digital health

By connecting dots between patients, physicians, medical research and more, digital health provides data-driven results to support life-changing decisions.

Do you know the symptoms of flu?

Influenza or "flu" is a viral infection that causes characteristic symptoms, which can help you identify it early and seek treatment.

Recognise the impact of flu

Flu is one of the most common infectious diseases, representing a serious threat to public health.

Cancer genomic testing – Debbie Rhea’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient; Debbie Rhea about the real-world impact it can have.

Cancer genomic testing – Jamal Tamer’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient; Jamal Tamer about the real-world impact it can have.

Meet our Roche pRED scientists

Learn more about our scientists and how they are tackling many devastating diseases.

Reimagining breast cancer with a new palette of pink

Each woman has her own story of cancer, her own shade of pink. We explore the stories of different women who share their unique experience with breast cancer.

Understanding MS as a progressive disease from the start

World-leading neurologists share their opinion on MS as a progressive disease from the start.

Autism Spectrum Disorder: A journey with unique challenges

Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.

Learning about the science behind NMOSD

Understanding neuromyelitis optica spectrum disorder (NMOSD) and the role of interleukin-6 in the inflammation that occurs in people with NMOSD

Living with NMOSD: Advice from a working mother

Ana has neuromyelitis optica spectrum disorder (NMOSD) but has learnt to understand her condition and remain positive. She shares her story here

Will genomics revolutionise the future of medicine?

Joanne Hackett talks about genomics, healthcare, big data and people’s hesitation to share medical data.

Two dimensions of confidence in clinical decision making

For patients, a cancer diagnosis changes everything. Former cancer patient Yvonne shares her story and why greater patient access to medical knowledge is critical to improving care.

The value of clinical decision support

Because patients need certainty.

Will quantum computers solve the problems of the future?

Martin Strahm talks about the idea, the potential and the limitations of quantum computers.

Building bridges to improve the cancer patient journey

The role of an oncology nurse navigator requires a unique combination of skills, knowledge and compassion.

Tip of the iceberg: the hidden impact of Alzheimer’s disease

Caring for people with Alzheimer’s disease has a huge economic and emotional impact. Learn about the intangible costs and Freeha’s experience with her father.

Our approach to sustainability

Roche Diagnostics product portfolio

Roche Diagnostics is transforming the way diseases can be prevented, diagnosed and monitored.

Decision support

A new level of certainty

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Liver cancer

HCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.

Women’s health

No matter what stage of life or part of the world a woman is in, knowledge is power.

Taking control of IPF: A tale of two perspectives

Rainer, who was diagnosed with idiopathic pulmonary fibrosis (IPF) after two stressful years of uncertainty, tells his story on living with IPF alongside expert advice from his doctor.

Understanding the role of the microbiome in IBD

Unlocking the mysteries of the gut’s unique and diverse environment of micro-organisms to help improve patient treatment outcomes.

A journey towards mutual understanding in IBD

A look at the importance of patient-physician communication in ulcerative colitis and Crohn’s disease, and how we are developing digital tools to help address this.

Uncovering stories of progression from the MS community

The MS community shares what they want others to know about the often invisible symptoms of MS, as well as their journey to managing its hidden impact.

Responding to natural disasters sustainably

For communities that have experienced a major natural disaster, we support community rebuilding and humanitarian projects.

Transnet-Phelophepa healthcare train

The Transnet-Phelophepa trains are mobile healthcare clinics that travel nine months out of the year to areas of rural South Africa.

Piecing together the puzzle of IBD

Read how we are approaching personalised healthcare in IBD to support individualised care for people living with ulcerative colitis and Crohn’s disease.

What is IBD?

IBD is a group of complex, chronic conditions, characterised by prolonged inflammation of the gastrointestinal tract, which can have a long-term impact on a patient's quality of life.

Roche's personalised approach in IBD

Compare today's approach in IBD with the ideal future

Changing the colorectal cancer story

Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Our mission is rooted in our formula: follow the science to preserve what makes people who they are.

Personalised Healthcare

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

Reimagining digital health regulation

For timely access to technologies that improve health decisions, health authorities are rethinking regulations for the uniquely iterative world of software.

The role of diagnostics in fertility and pregnancy

Learn more about advanced screening and diagnostics tests and their role in preconception and pregnancy.

About the importance of disease awareness

Four key factors need to be in place to successfully treat a patient, the first factor is disease awareness.

Hepatitis B - Aiming for cure of a killer

Hepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.

ForPatients

Developed in partnership with patients, ForPatients aims to support patients on their journey.

A woman's right to know: HPV and cervical cancer

The HPV test came back positive – what now? Should women be worried? What should they do next?

Unveiling triple-negative breast cancer

Lifting the curtain on an often overlooked disease.

Striking back at stroke risk

Why less is more in atrial fibrillation management

Addressing the lack of cancer care in Pakistan

Our access to healthcare initiatives

Explore some of our access projects from around the globe.

Increasing access to healthcare

Groundbreaking advances in medical science are only meaningful when they reach the people who need them.

Increasing access to healthcare is a global challenge

Finding sustainable solutions to the barriers to healthcare can only be achieved through collaboration.

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Improving access to hepatitis treatment in Egypt

Comprehensive access to cancer treatment in Dubai

A platform for supporting cancer patients in India

India does not have a centralised healthcare funding body and access to medicines is not universal.

Improving cancer care in Bosnia and Herzegovina

Let’s talk fertility

Women and their bodies may have very different ideas about the right time to have a baby.

Strengthening communities

We are committed to building stronger communities and responding to natural disasters sustainably.

Our approach to philanthropy

We engage in philanthropic activities that make a lasting impact and strengthen communities.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Making HIV testing accessible

The Global Access Programme makes HIV viral load tests and the early detection of infections in infants possible in countries that are most affected by the disease.

Our Approach to Cancer Immunotherapy

Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.

About the importance of funding

Four key factors need to be in place to successfully treat a patient, with funding being the most controversial one.

About the importance of healthcare capacity

Healthcare capacity is one of four key factors that need to be in place to successfully treat a patient.

About the importance of diagnosis

Four key factors need to be in place to successfully treat a patient, with diagnosis being one of them.

Our approach to increase access to healthcare

Access to healthcare is a complex challenge. Four key factors need to be in place to improve access to quality healthcare.

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Digital solutions supporting rheumatoid arthritis community

It has become natural for people to seek information or advice about their health online. Learn about three solutions we developed for the European RA community.

Mesothelioma: What could possibly link this rare cancer to the ill-fated Titanic?

What could possibly link this rare cancer to the ill-fated Titanic?

Busting myths in lung cancer

How much do you really know about lung cancer? Our interactive flashcards bust some common myths about lung cancer.

Expecting more for people with PPMS

Dr. Jerome de Seze, explains how recent clinical advances mean more and more people are being diagnosed with PPMS.

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Protecting against progression

Dr. Traboulsee, University of British Columbia in Vancouver, discusses the importance of brain health and early treatment for people with multiple sclerosis.

Beyond the immunity cycle

Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.

Roche in Alzheimer’s disease

Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

Buttons - daily enemies for people with rheumatoid arthritis

New clothing collection designed to overcoming issues that people with RA face when getting dressed.

Rheumatoid arthritis through the lens of an Slovenian artist

A photographer captures what it means to live with the consequences of rheumatoid arthritis.

Providing a helping hand for people with rheumatoid arthritis

A collaboration with the Brazilian patient advocacy group helps to improve the quality of life of people living with RA.

Life with rheumatoid arthritis through pictures and words

The three artists captured what living with the disease means to people with rheumatoid arthritis.